MarketInOut Stock Screener Log In | Sign Up

China Regenerative Medicine International Ltd

HKSE • Healthcare • Biotechnology • Quote as of 10/30/2026
China Regenerative Medicine International Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeHKSE
Market Capitalization77.58 mln
Float249 mln
Earnings Date04/01/2027

EPS

0.09
Marginal

P / E

2.72
Deeply undervalued

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.72
Likely reliable

Relative Strength

5 / 100
Severely lagging

Debt / Equity

0.67
Moderate leverage

Business Description

Founded in 1995 and based in Hong Kong, China Regenerative Medicine International Limited develops and sells regenerative medicine and tissue engineering products across Hong Kong and China. The company runs two main lines of business: medical services and aesthetic and beauty treatments. Its offerings range from anti-aging therapies, hair restoration, and scar removal to slimming, skin care, acupuncture, endoscopy, and general health testing and vaccines.

Key Fundamentals

EPS0.09
P/E2.72
ROE59.31
RPS0.28
ROIC5.59
ROA17.61
Interest Cover4.31
EBITDA, mln26.99
EV / EBITDA4.67
EV / EBIT7.51
Revenue, mln86.40
EV / Revenue1.46

Quote Details

Last 0.245
Change -0.001 (-0.41%)
Open 0.245
Volume 10,000
Turnover 2,450
Average Volume 86,449

Financial Ratios

Pre-Tax Profit Margin18
Leverage Ratio2.52
Current Ratio1.57
Price / Book1.55
Price / Tangible Book1.55
Price / Cash Flow4.97
Price / Free Cash Flow5.78
Debt / Equity0.67
Price / Sales1.04

Financial Strength

Altman Z-Score-21.99
Piotroski F-Score 7 / 9
Beneish M-Score-2.72
Price to Graham Number0.48

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -7.55% 18 / 100   
1 Month 28.95% 97 / 100   
2 Months -30% 16 / 100   
6 Months -38.75% 23 / 100   
1 Year -47.31% 24 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog